Physician

Charu L Trivedi, MD

According to 2025 Medicare claims, Charu Trivedi, MD (NPI: 1386641397) practices hematology/oncology in the Monroe, MI market, with the plurality of this provider's patient population coming from Monroe, MI. This provider's primary affiliated billing organization is TOLEDO CLINIC INCORPORATED (NPI: 1669423455; TIN: 340936207) and primary practice location at 48162-4226. Trivedi is affiliated with the Mercy Health Select, LLC (ACO ID: A1215) and CVS Accountable Care Organization, Inc. (ACO ID: D0061), participating under both the MSSP and REACH models.

Trivedi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 455 traditional Medicare patients, billed 99,240 HCPCS/CPT codes, and received $1,743,432 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,010 prescription claims across 241 beneficiaries totaling $3,274,686 in drug costs, led by Ibrance (Palbociclib). 2023 DME data shows 36 claims. Open Payments data shows 1 records totaling $89. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,184,611 and ending at $1,743,432. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,232,498 to $3,274,686. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$872K$1.7M2015 Medicare payment: $1,184,611 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,588,019 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,329,926 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,554,601 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,043,421 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,101,023 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,399,892 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,711,061 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,088,595 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,743,432 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015698209,763$1,184,611
2016673177,477$1,588,019
2017840119,923$1,329,926
2018799125,749$1,554,601
201980594,722$1,043,421
202068383,188$1,101,023
2021649113,484$1,399,892
2022515118,172$1,711,061
202343168,856$1,088,595
202445599,240$1,743,432

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.6M$3.3M2015 Drug cost: $1,232,498 (USD; Tot_Drug_Cst)2016 Drug cost: $1,226,761 (USD; Tot_Drug_Cst)2017 Drug cost: $966,688 (USD; Tot_Drug_Cst)2018 Drug cost: $1,408,161 (USD; Tot_Drug_Cst)2019 Drug cost: $1,075,134 (USD; Tot_Drug_Cst)2020 Drug cost: $1,825,383 (USD; Tot_Drug_Cst)2021 Drug cost: $2,025,042 (USD; Tot_Drug_Cst)2022 Drug cost: $2,316,706 (USD; Tot_Drug_Cst)2023 Drug cost: $2,448,224 (USD; Tot_Drug_Cst)2024 Drug cost: $3,274,686 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015231945$1,232,498
2016223905$1,226,761
2017223830$966,688
2018240830$1,408,161
2019216721$1,075,134
2020187699$1,825,383
2021210702$2,025,042
2022185672$2,316,706
2023194685$2,448,224
20242411,010$3,274,686

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$3.4K$6.8K2015 Medicare payment: $544 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $4,907 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $920 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $6,822 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R11$544
2016N/R48$4,907
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R14$920
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/R36$6,822
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more5656$113
96413Administration of chemotherapy into vein, 1 hour or less43256$90
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more3761,076$85
96367Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less37174$21
96372Injection of drug or substance under skin or into muscle56303$10

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
IbrancePalbociclib772,156$1,173,237
XtandiEnzalutamide341,020$460,092
ImbruvicaIbrutinib30840$458,732
VenclextaVenetoclax13390$203,377
JakafiRuxolitinib Phosphate12360$191,032

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$89Gilead Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Charu L. Trivedi, MD?

Tedicare shows public-source Medicare data for Charu L. Trivedi, MD (NPI 1386641397), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charu L. Trivedi, MD have ACO affiliation data?

Charu L. Trivedi, MD is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215) and CVS Accountable Care Organization, Inc. (REACH, ACO ID D0061).

What billing organization is linked to Charu L. Trivedi, MD?

Charu L. Trivedi, MD is linked to TOLEDO CLINIC INCORPORATED (billing NPI 1669423455) in the available physician profile data.

Does Charu L. Trivedi, MD have Open Payments data?

Charu L. Trivedi, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.